Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.6% |
| 2 | Technology | 19.83% |
| 3 | Financials | 7.37% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
701
Jack Henry & Associates
JKHY
$9.99B
| $50.9M | 0.01% |
282,521
+149
| +0.1% | +$26.5K |
2013 Q2
48 quarters
|
|
702
PTC
PTC
$15.6B
| $50.8M | 0.01% |
294,916
+42,977
| +17% | +$6.93M |
2013 Q2
48 quarters
|
|
703
Insulet
PODD
$9.13B
| $50.8M | 0.01% |
161,720
+35,671
| +28% | +$10.3M |
2013 Q2
48 quarters
|
|
704
CALL
AstraZeneca
AZN
$243B
| $50.7M | 0.01% |
362,500
+45,000
| +14% | +$6.31M |
2025 Q1
1 quarter
|
|
705
Pinnacle West Capital
PNW
$11.6B
| $50.5M | 0.01% |
564,508
-109,369
| -16% | -$10M |
2013 Q2
48 quarters
|
|
706
CALL
Strategy Inc
MSTR
$63.8B
| $50.5M | 0.01% |
124,900
-377,800
| -75% | -$138M |
2024 Q2
4 quarters
|
|
707
SBA Communications
SBAC
$16.8B
| $50.4M | 0.01% |
214,508
+33,609
| +19% | +$7.69M |
2013 Q2
48 quarters
|
|
708
Eastman Chemical
EMN
$7.42B
| $50.4M | 0.01% |
674,639
+136,114
| +25% | +$10.7M |
2013 Q2
48 quarters
|
|
709
Annaly Capital Management
NLY
$13.9B
| $50.3M | 0.01% |
2,674,061
+2,219,558
| +488% | +$42.2M |
2013 Q2
48 quarters
|
|
710
WIX.com
WIX
$3.04B
| $50.2M | 0.01% |
316,979
+204,671
| +182% | +$33M |
2016 Q2
36 quarters
|
|
711
Halliburton
HAL
$26.5B
| $50.1M | 0.01% |
2,457,863
-825,060
| -25% | -$17.3M |
2013 Q2
48 quarters
|
|
712
Align Technology
ALGN
$10.2B
| $50M | 0.01% |
264,299
-24,271
| -8% | -$4.29M |
2013 Q2
48 quarters
|
|
713
Flex
FLEX
$43.1B
| $49.7M | 0.01% |
995,229
-48,848
| -5% | -$1.9M |
2013 Q4
46 quarters
|
|
714
Viatris
VTRS
$20.2B
| $49.4M | 0.01% |
5,531,544
+2,163,835
| +64% | +$18.3M |
2022 Q1
13 quarters
|
|
715
iShares Biotechnology ETF
IBB
$10.5B
| $49.4M | 0.01% |
390,159
-330,506
| -46% | -$40.6M |
2013 Q2
48 quarters
|
|
716
DaVita
DVA
$11.4B
| $49.3M | 0.01% |
345,774
+184,977
| +115% | +$26.2M |
2013 Q2
48 quarters
|
|
717
PUT
JD.com
JD
$34.8B
| $49.3M | 0.01% |
1,508,900
+1,420,400
| +1,605% | +$48.5M |
2024 Q3
3 quarters
|
|
718
Energy Transfer Partners
ET
$70.5B
| $49.1M | 0.01% |
2,708,733
-1,516,087
| -36% | -$26.5M |
2013 Q2
48 quarters
|
|
719
Baxter International
BAX
$12.1B
| $48.8M | 0.01% |
1,611,754
+422,919
| +36% | +$12.8M |
2013 Q2
48 quarters
|
|
720
PVH
PVH
$3.48B
| $48.8M | 0.01% |
710,799
+556,634
| +361% | +$40.4M |
2013 Q2
48 quarters
|
|
721
Avery Dennison
AVY
$12.9B
| $48.5M | 0.01% |
276,356
-38,442
| -12% | -$6.74M |
2013 Q2
48 quarters
|
|
722
Remitly
RELY
$4.61B
| $48.4M | 0.01% |
2,578,114
+1,412,196
| +121% | +$29.4M |
2022 Q1
13 quarters
|
|
723
UDR
UDR
$10.7B
| $48.1M | 0.01% |
1,178,055
+517,364
| +78% | +$21.4M |
2013 Q2
48 quarters
|
|
724
Hubbell
HUBB
$25.1B
| $48.1M | 0.01% |
117,744
-11,443
| -9% | -$4.24M |
2015 Q4
38 quarters
|
|
725
CALL
AB InBev
BUD
$145B
| $48M | 0.01% |
698,000
+398,000
| +133% | +$26.7M |
2023 Q4
6 quarters
|
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2025 filing shows 461 new, 2,914 increased, 1,345 reduced and 463 closed positions. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M. The largest sale was Honeywell, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 41% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.